Valirx Planning Endometriosis Clinical Test of Its Anti-Cell Growth Candidate …

Valirx Planning Endometriosis Clinical Test of Its Anti-Cell Growth Candidate …

… company specializing in oncology therapeutics and diagnostics with a particular focus on cancer treatments and associated biomarkers, is conducting a Phase 1/2 clinical trial of its drug candidate VAL201 on people with hormone-resistant prostate

(Visited 1 times, 1 visits today)
1
Like
Save

Comments

Comments are disabled for this post.